Company / EPS (Diluted)
Mind Medicine (MindMed) Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.06
FY2025
5-year range
-$3.40 / -$1.54
FY2021-FY2025
Trend
-33.8%
vs FY2024
Sector context
#126 of 204
Health Care
What the data says
At $-2.06, Mind Medicine (MindMed) Inc.'s eps (diluted) ranks #126 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 5 years, ranging from $-3.40 in FY2021 to $-1.54 in FY2024.
Based on SEC 10-K filings.
-2.06 in FY2025.
Improved from $-2.44 to $-2.06 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 204 in Health CareTop 62% of 204This company -$2.06 Sector average -$0.89
▼
-132.4% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 33.8% year-over-year.
- Ranks #126 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.06 | -33.8% |
| FY2024 | -$1.54 | +36.9% |
| FY2023 | -$2.44 | -32.6% |
| FY2022 | -$1.84 | +45.9% |
| FY2021 | -$3.40 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026